Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 38Pancreatic Neoplasms 21Stomach Neoplasms 16Colonic Neoplasms 13Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 11Adenocarcinoma Of Esophagus 11Rectal Neoplasms 10Neoplasm Metastasis 10Esophageal Neoplasms 10Neoplasms 9Cholangiocarcinoma 6Adenocarcinoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Leukemia, Biphenotypic, Acute 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Esophageal Squamous Cell Carcinoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Advanced Solid Tumors 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Myelodysplastic Syndromes 2Lymphoma 2Leukemia 2Down Syndrome 2

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 2pembrolizumab 1dehydroftorafur 1atezolizumab 1RAD51C protein, human 1Oxaliplatin 1Naproxen 1Leucovorin 1Health Promotion 1Genetic Testing 1G-T mismatch-binding protein 1Fluorouracil 1Endoscopy 1Educational Status 1Diffusion Tensor Imaging 1Diet Therapy 1Data Collection 1Colonoscopy 1Capsule Endoscopy 1Biopsy 1Aspirin 1Artificial Intelligence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms, Hereditary Nonpolyposis × Leucovorin × 90 days × Clear all
NCT02912559 2026-06-01

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

National Cancer Institute (NCI)

Phase 3 Active not recruiting
712 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡